However, in both mouse and human cancers, progression to invasive primary tumors was accompanied by a clear decrease in TIGAR expression (Figures 7A–7D), consistent with the selection for cells with higher ROS and higher invasive capacity during these stages of tumorigenesis. This evidence concerns the gene TIGAR and cancer.